CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 118 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 3.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $399,000 | +35.3% | 86,400 | -2.1% | 0.01% | +25.0% |
| Q4 2020 | $295,000 | +12.2% | 88,282 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $263,000 | -87.4% | 88,282 | -80.4% | 0.00% | -86.2% |
| Q2 2020 | $2,080,000 | +20.0% | 450,182 | 0.0% | 0.03% | +3.6% |
| Q1 2020 | $1,734,000 | +2.1% | 450,182 | 0.0% | 0.03% | +64.7% |
| Q4 2019 | $1,698,000 | +24157.1% | 450,182 | +37986.5% | 0.02% | – |
| Q3 2019 | $7,000 | +40.0% | 1,182 | 0.0% | 0.00% | – |
| Q2 2019 | $5,000 | -28.6% | 1,182 | 0.0% | 0.00% | – |
| Q1 2019 | $7,000 | +133.3% | 1,182 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | -25.0% | 1,182 | 0.0% | 0.00% | – |
| Q3 2018 | $4,000 | 0.0% | 1,182 | 0.0% | 0.00% | – |
| Q2 2018 | $4,000 | +33.3% | 1,182 | +8.1% | 0.00% | – |
| Q1 2018 | $3,000 | -25.0% | 1,093 | 0.0% | 0.00% | – |
| Q4 2017 | $4,000 | – | 1,093 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $1,902,000 | 5.68% |
| GABLES CAPITAL MANAGEMENT INC. | 433,814 | $5,566,000 | 4.46% |
| Quantedge Capital Pte Ltd | 503,700 | $6,462,000 | 1.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,896,000 | $62,816,000 | 1.25% |
| Lanham O'Dell & Company, Inc. | 20,145 | $258,000 | 0.92% |
| Capital Impact Advisors, LLC | 59,301 | $907,000 | 0.90% |
| SummerHaven Investment Management, LLC | 98,840 | $1,268,000 | 0.88% |
| Yorktown Management & Research Co Inc | 50,000 | $642,000 | 0.83% |
| GLOBEFLEX CAPITAL L P | 304,293 | $3,904,000 | 0.67% |
| AFFINITY INVESTMENT ADVISORS, LLC | 90,864 | $1,166,000 | 0.60% |